by abrickmicrobiologicscom | Nov 8, 2018 | Clinical, Pharmaceutical
Moraxella osloensis isn’t a well-known bacterium outside the laboratory, but this opportunistic human pathogen has been found to cause life-threatening diseases such as endocarditis, osteomyelitis, central venous catheter infection and meningitis.1 M. osloensis is...
by Stanley Staphylococcus | Oct 18, 2018 | Clinical, Molecular
Dear Stanley, I’m completely confused about the terms “assayed” and “unassayed” in relation to controls for molecular diagnostic instruments. Does “unassayed” mean the manufacturer of the control hasn’t tested the products? Can you shed some light on...
by Ashley Umlauf | Sep 20, 2018 | Clinical, Molecular
Cold and flu season is right around the corner. These annual illnesses are often paired with another highly contagious infection, strep throat. Its culprit, Group A Streptococcus, can cause a variety of other illnesses including invasive diseases such as cellulitis...
by Tina Sobania | Sep 13, 2018 | Clinical, Molecular
There are many misconceptions in the clinical industry regarding laboratory quality control materials. With numerous products available and manufacturers using various labeling practices, how do you know what’s best for your laboratory? To help clear up the confusion,...
by Ashley Umlauf | Aug 30, 2018 | Clinical, Molecular
Sepsis is estimated to affect more than 30 million people worldwide every year6 and is also one of the leading causes of death in hospitals throughout the United States7. To raise awareness of this condition, several organizations recognize September as Sepsis...
by Stanley Staphylococcus | Aug 23, 2018 | Clinical, Food, Pharmaceutical, Water
Dear Stanley, When performing growth promotion with Microbiologics products, do you recommend testing in parallel with a previously approved media? The USP, EP, and JP don’t require testing in parallel. They only state “Test each batch of ready-prepared medium and...
